Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

DALLAS, Feb. 06, 2026 (GLOBE NEWSWIRE) — Taysha Gene Therapies, Inc. (Nasdaq: TSHA) (Taysha or the Company), a clinical-stage biotechnology company focused on advancing adeno-associated virus (AAV)-based gene therapies for severe monogenic diseases of the central nervous system (CNS), today announced that, on February 2, 2026, the Compensation Committee of Taysha’s Board of Directors granted […]


1 M.
Science
ID: -1169812457719145274


Similar News expand_more


Science
Science
Science
Science
Science
Science
Science
Science
Technology
Science
Science
Science
Science
Technology
Science
Science
Technology
Science
Science
Economics
Technology
Technology
Science
Technology
Economics
Science
Technology
Technology
Technology
Economics
Education
Science
Technology
Science
Education
Science
Science
Education
Science
Science
Economics
Science
Science
Technology
Science
Technology
Science
Technology
Science
Popular countries based on strong economic and political relations

Add Watch Country

arrow_drop_down